Diagnostic News and Research

RSS

bioTheranostics launches CancerTYPE ID database and KRAS mutational testing

bioTheranostics, a bioMerieux company that discovers, develops and commercializes innovative molecular diagnostic tests in oncology, announces the launch of an expanded tumor-type database for its flagship product, CancerTYPE ID®, and the launch of KRAS mutational testing.

5 Mar 2010

Diamedix and Delta Biologicals’ suite of diagnostic tests: Fumouze Diagnostics to be exclusive distributor in France

IVAX Diagnostics, Inc., a fully integrated global in vitro diagnostics company, announced that Diamedix Corporation has signed a distribution agreement with Fumouze Diagnostics, a division of Sofibel S.A.S., of Paris, France, pursuant to which Fumouze Diagnostics will be the exclusive third party distributor of Diamedix Corporation and Delta Biologicals S.r.l.’s suite of diagnostic tests in France. Diamedix is a U.S. subsidiary of IVAX Diagnostics and Delta Biologicals is IVAX Diagnostics’ subsidiary located in Italy. The initial term of the distribution agreement is three years.

5 Mar 2010

BioClinica announces partnerships with Health Sciences International and PRL Central Laboratory Services

BioClinica™, Inc.,, a global provider of clinical trial management services, today announced it has created strategic partnerships with two clinical research organizations (CROs), Health Sciences International, Inc., and PRL Central Laboratory Services. Both alliances strengthen the BioClinica Certified Partner Program, a group of VIP CRO partners chosen based on therapeutic expertise and customer satisfaction.

From Clario 5 Mar 2010

Positron announces the sale of Attrius PET scanner to Ochsner Health System of Louisiana

Positron Corporation a molecular imaging solutions company focused on Nuclear Cardiology, announced the sale of its AttriusTM PET scanner to Ochsner Health System of Louisiana.

5 Mar 2010

Accurate, life-saving diagnostic tools needed for screening and prevention of prostate cancer, says AdMeTech

AdMeTech President and CEO Dr. Faina Shtern told the U.S. House Committee on Oversight and Government Reform that a major national commitment is needed to create accurate, life-saving diagnostic tools for prostate cancer and end what she called "the prostate cancer crisis."

4 Mar 2010

Enigma Diagnostics opens new Regional HQ office in San Diego

Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today the opening of its new Regional HQ office in San Diego, CA and the appointment of Joel Centeno as VP Regulatory & Quality.

4 Mar 2010

CML Healthcare Income Fund reports increase revenue for 2009 fiscal year

CML HealthCare Income Fund today reported its financial results for the three and twelve-month periods ended December 31, 2009.

4 Mar 2010

P&R Dental Strategies develops and builds Rapid Review Imaging System for digitizing x-ray images

After nearly two decades building her company into the industry leader for third-party review of dental insurance claims, Dianne Rose, D.D.S., and principal of P&R Dental Strategies, Inc., was frustrated. In spite of many advances over the years in both dental x-ray technologies and the average quality of images supplied for review of dental claims, there was no consistency and, all-too-often, regardless of how up-to-date the x-ray equipment being used may have been, the images supplied were blurred and nearly useless for making accurate diagnostic determinations.

4 Mar 2010

University of Calgary chemist finds potential tool to measure impact of nanoparticles on human health

University of Calgary chemistry professor David Cramb is a step closer to helping solve a complex problem in nanotechnology: the impact nanoparticles have on human health and the environment.

4 Mar 2010

HbA1c levels help predict future diabetes more accurately than fasting glucose measurements

Measurements of hemoglobin A1c (HbA1c) more accurately identify persons at risk for clinical outcomes than the commonly used measurement of fasting glucose, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health.

4 Mar 2010

Abbott enters into agreement with GSK to develop molecular diagnostic test for skin cancer treatment

Abbott announced today that it has entered into an agreement with GlaxoSmithKline (GSK) to develop a molecular diagnostic test intended for use as an aid in selecting patients who may benefit from a skin cancer treatment in development by GSK.

4 Mar 2010

New federal guidelines on breast cancer screening: Stanford experts disagree

At a recent community education program, Stanford experts on women’s cancer disagreed with controversial new federal guidelines on breast cancer screening. The new guidelines, released in November by the U.S. Preventive Services Task Force, would delay a woman’s first mammogram by 10 years, reduce future screenings from annual to every other year, and end them after age 74.

4 Mar 2010

PCF: PSA screening remains valuable tool for identifying potential prostate disease

Responding to continued debate over PSA screening, and today’s American Cancer Society statement, the Prostate Cancer Foundation reiterated its position that PSA screening remains a valuable tool, in combination with other tools, for identifying potential prostate disease, including cancer.

4 Mar 2010

Lemelson-MIT Collegiate Student Prizes awarded to inventive students nationwide

A scientific "Renaissance man" whose work spans the fields of mathematics, linguistics, biotechnology and polymer physics, Erez Lieberman-Aiden, graduate student at the Harvard-MIT Division of Health Sciences and Technology, has been named the winner of the prestigious $30,000 Lemelson-MIT Student Prize. Lieberman-Aiden, one of four 2010 $30,000 Lemelson-MIT Collegiate Student Prize winners announced today, was selected for the breadth and depth of his innovations.

4 Mar 2010

Researchers launch new project to diagnose and treat dementia among Deaf people who use BSL

Researchers have launched a unique project to improve early diagnosis and management of dementia among Deaf people who use British Sign Language (BSL).

From The University of Manchester 3 Mar 2010

NextGen Healthcare Information Systems wins MS-HUG 2010 Innovation Awards for Interoperability/HIE

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced it has been recognized as a winner of the Microsoft® Healthcare Users Group (MS-HUG) 2010 Innovation Awards in the category of Interoperability/HIE.

3 Mar 2010

VUCCC files for patent protection: New treatment regimen for Type 1 insulin-dependent diabetes

VUCCC P/L is pleased to announce that it has filed for patent protection of its ground breaking new treatment regimen for Type 1 'insulin-dependent' diabetes, through the European Patent Office.

3 Mar 2010

Children’s Mercy Hospitals and Clinics installs Infinix CF-i/BP vascular X-ray systems

To bring the latest in cardiovascular X-ray technology to its pediatric patients, Children’s Mercy Hospitals and Clinics in Kansas City, Mo., has installed two InfinixTM CF-i/BP vascular X-ray systems with 8" x 8" flat panel detectors (FPD) from Toshiba America Medical Systems, Inc. These systems are the first pediatric bi-plane systems in the U.S. equipped with Toshiba’s Next Generation Advanced Image Processing (AIP) capabilities.

3 Mar 2010

Merge Healthcare, MGH sign agreement to build testing environment for new mobile healthcare applications

Based on their respective expertise in imaging IT and clinical workflow, Merge Healthcare and Massachusetts General Hospital have signed a partnership agreement to build a testing environment for new mobile healthcare applications.

3 Mar 2010

China Medical Technologies reports revenues of US$25.2 million for third-quarter fiscal 2009

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced its unaudited financial results for the third fiscal quarter ended December 31, 2009 ("3Q FY2009"). The Company's 2009 fiscal year ends on March 31, 2010 ("FY2009").

3 Mar 2010

Diagnostic News and Research

bioTheranostics launches CancerTYPE ID database and KRAS mutational testing

Diamedix and Delta Biologicals’ suite of diagnostic tests: Fumouze Diagnostics to be exclusive distributor in France

BioClinica announces partnerships with Health Sciences International and PRL Central Laboratory Services

Positron announces the sale of Attrius PET scanner to Ochsner Health System of Louisiana

Accurate, life-saving diagnostic tools needed for screening and prevention of prostate cancer, says AdMeTech

Enigma Diagnostics opens new Regional HQ office in San Diego

CML Healthcare Income Fund reports increase revenue for 2009 fiscal year

P&R Dental Strategies develops and builds Rapid Review Imaging System for digitizing x-ray images

University of Calgary chemist finds potential tool to measure impact of nanoparticles on human health

HbA1c levels help predict future diabetes more accurately than fasting glucose measurements

Abbott enters into agreement with GSK to develop molecular diagnostic test for skin cancer treatment

New federal guidelines on breast cancer screening: Stanford experts disagree

PCF: PSA screening remains valuable tool for identifying potential prostate disease

Lemelson-MIT Collegiate Student Prizes awarded to inventive students nationwide

Researchers launch new project to diagnose and treat dementia among Deaf people who use BSL

NextGen Healthcare Information Systems wins MS-HUG 2010 Innovation Awards for Interoperability/HIE

VUCCC files for patent protection: New treatment regimen for Type 1 insulin-dependent diabetes

Children’s Mercy Hospitals and Clinics installs Infinix CF-i/BP vascular X-ray systems

Merge Healthcare, MGH sign agreement to build testing environment for new mobile healthcare applications

China Medical Technologies reports revenues of US$25.2 million for third-quarter fiscal 2009

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News